Drugs Made In America Acquisition II Corp. (DMIIR) › Operating Cash FlowDrugs Made In America Acquisition II Corp. (DMIIR) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.Fiscal YearOperating Cash FlowChange YoY2025-$1.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share